12(S)-Hydroxyheptadeca-5Z,8E,10E-trienoic
acid (12- HHT) is an enzymatic product of
prostaglandin H(2) (
PGH(2)) derived from
cyclooxygenase (COX)-mediated
arachidonic acid metabolism. Despite the high level of
12-HHT present in tissues and bodily fluids, its precise function remains largely unknown. In this study, we found that
12-HHT treatment in HaCaT cells remarkably down-regulated the ultraviolet B (UVB) irradiation-induced synthesis of
interleukin-6 (IL-6), a pro-inflammatory
cytokine associated with cutaneous
inflammation. In an approach to identify the down-stream signaling mechanism by which
12-HHT down-regulates UVB-induced
IL-6 synthesis in keratinocytes, we observed that
12-HHT inhibits the UVB-stimulated activation of
p38 mitogen-activated protein kinase (MAPK) and
nuclear factor kappa B (NF-κB). In addition, we found that
12-HHT markedly up-regulates MAPK phosphatase-1 (MKP-1), a critical negative regulator of
p38 MAPK. When MKP-1 was suppressed by
siRNA knock-down, the 12-HHT-mediated inhibitory effects on the UVB-stimulated activation of
p38 MAPK and NF-κB, as well as the production of
IL-6, were attenuated in HaCaT cells. Taken together, our results suggest that
12-HHT exerts anti-inflammatory effect via up-regulation of MKP-1, which negatively regulates
p38 MAPK and NF-κB, thus attenuating
IL-6 production in UVB-irradiated HaCaT cells. Considering the critical role of
IL-6 in cutaneous
inflammation, our findings provide the basis for the application of
12-HHT as a potential anti-inflammatory therapeutic agent in UV-induced
skin diseases.